SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity
Open Access
- 17 May 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (6) , 102036
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
- Virginia Commonwealth University
This publication has 76 references indexed in Scilit:
- TRAF molecules in cell signaling and in human diseasesJournal of Molecular Signaling, 2013
- Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunityProceedings of the National Academy of Sciences, 2011
- Pathogenic Microbes and Community Service Through Manipulation of Innate Immunity2011
- Expanding role of ubiquitination in NF-κB signalingCell Research, 2010
- RING Domain E3 Ubiquitin LigasesAnnual Review of Biochemistry, 2009
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIKNature Immunology, 2008
- A review of the relationship between tooth loss, periodontal disease, and cancerCancer Causes & Control, 2008
- Control of canonical NF-κB activation through the NIK–IKK complex pathwayProceedings of the National Academy of Sciences, 2008
- Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 2005
- Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 2005